Case of Chemotherapy-Refractory, RAS-Mutated Chronic Myelomonocytic Leukemia Responsive to Single-Agent Trametinib Based on Results From a High-Throughput Drug Screen

Anna B Halpern^{1

2}, Timothy J Martins³, Erica C Jonlin³, Jin Dai¹, Sylvia Chien¹, Pamela S Becker^{1

2

3

4}

Affiliations

¹ Department of Medicine, Division of Hematology, University of Washington, Seattle, WA.
² Clinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington, Seattle, WA.
³ Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA.
⁴ Division of Hematology/Oncology, Chao Family Comprehensive Cancer Center, University of California, Irvine, Irvine, CA.

Anna B Halpern et al. JCO Precis Oncol. 2020 Nov.

. 2020 Nov:4:1367-1373.

doi: 10.1200/PO.20.00270.

Anna B Halpern^{1

2}, Timothy J Martins³, Erica C Jonlin³, Jin Dai¹, Sylvia Chien¹, Pamela S Becker^{1

2

3

4}

¹ Department of Medicine, Division of Hematology, University of Washington, Seattle, WA.
² Clinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington, Seattle, WA.
³ Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA.
⁴ Division of Hematology/Oncology, Chao Family Comprehensive Cancer Center, University of California, Irvine, Irvine, CA.

No abstract available

LinkOut - more resources